Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023–2024
Stephanie A. Irving(Kaiser Permanente Center for Health Research), Allison L. Naleway(Centers for Disease Control and Prevention), Matthew F. Daley(Kaiser Permanente), Ousseny Zerbo(Kaiser Permanente), Brian E. Dixon(Regenstrief Institute), Sean T. O’Leary(University of Colorado Anschutz Medical Campus), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Sungching Glenn, Hilda Razzaghi(National Center for Immunization and Respiratory Diseases), James G. Donahue(Brigham and Women's Hospital), Karen B. Jacobson(Boston University), Candace C. Fuller(Harvard University), Katharine Sznajder(Kaiser Permanente), Teresa Schmidt(Portland State University), Sharon Fuller(Kaiser Permanente Washington Health Research Institute), Elyse O. Kharbanda(HealthPartners), Eric Weintraub, Judith C. Maro(Harvard University), Simon J. Hambidge, Suchita A. Patel(Centers for Disease Control and Prevention), Nancy S. Weinfield(University of Minnesota), Joshua T.B. Williams(Denver Health Medical Center), Bradley Crane, Darios Getahun(Kaiser Permanente)
Cited by 17
Related Papers
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|2.4k
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Human Papillomavirus–Associated Cancers — United States, 2008–2012
|MMWR Morbidity and Mortality Weekly Report|2016|876
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661